← Evidence map

ReviewCancers2022

Cancer as a Channelopathy-Appreciation of Complimentary Pathways Provides a Different Perspective for Developing Treatments.

Harry J Gould et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36230549